Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Rio de la Plata Estuary: 16S rRNA amplicon sequence data

ABSTRACT: Bacterioplankton composition as indicator of environmental status: proof of principle using indicator value analysis of estuarine communities

PROVIDER: PRJEB29989 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR3011860.fastq.gz	Fastqsanger.gz
	ERR3011870.fastq.gz	Fastqsanger.gz
	ERR3011861.fastq.gz	Fastqsanger.gz
	ERR3011871.fastq.gz	Fastqsanger.gz
	ERR3011862.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 37

Similar Datasets

Proteomics for Newport Estuary Samples

Project description:Microorganisms are key contributors to biogeochemical flux in estuarine ecosystems. In this study, we conducted proteogenomic characterization of microbial communities from estuarine ecosystems.

2018-07-04 | PXD008093 | Pride

Project description:ChAMP proof of principle

| PRJNA1041053 | ENA

Gene expression from iPS derived neurons exposed to plasma from Alzheimer's (AD), pre-symptomatic AD, or control patients.

Project description:We have established proof of principle for the Indicator Cell Assay Platformé (iCAPé), a broadly applicable tool for blood-based diagnostics that uses specifically-selected, standardized cells as biosensors, relying on their innate ability to integrate and respond to diverse signals present in patientsÕ blood. To develop an assay, indicator cells are exposed in vitro to serum from case or control subjects and their global differential response patterns are used to train reliable, cost-effective disease classifiers based on a small number of features. In a feasibility study, the iCAP detected pre-symptomatic disease in a murine model of amyotrophic lateral sclerosis (ALS) with 94% accuracy (p-Value=3.81E-6) and correctly identified samples from a murine HuntingtonÕs disease model as non-carriers of ALS. In a preliminary human disease assay, the iCAP detected early stage AlzheimerÕs disease with 72% cross-validated accuracy (p-Value=3.10E-3). For both assays, iCAP features were enriched for disease-related genes, supporting the assayÕs relevance for disease research.

2017-03-17 | GSE95810 | GEO

Gene expression from embryoid bodies derived from HBG3 HB9 ES cells exposed to serum from mice carrying an ALS causing mutation, or non-carrier littermates.

Project description:We have established proof of principle for the Indicator Cell Assay PlatformÈ (iCAPÈ), a broadly applicable tool for blood-based diagnostics that uses specifically-selected, standardized cells as biosensors, relying on their innate ability to integrate and respond to diverse signals present in patientsê blood. To develop an assay, indicator cells are exposed in vitro to serum from case or control subjects and their global differential response patterns are used to train reliable, cost-effective disease classifiers based on a small number of features. In a feasibility study, the iCAP detected pre-symptomatic disease in a murine model of amyotrophic lateral sclerosis (ALS) with 94% accuracy (p-Value=3.81E-6) and correctly identified samples from a murine Huntingtonês disease model as non-carriers of ALS. In a preliminary human disease assay, the iCAP detected early stage Alzheimerês disease with 72% cross-validated accuracy (p-Value=3.10E-3). For both assays, iCAP features were enriched for disease-related genes, supporting the assayês relevance for disease research.

2017-03-17 | GSE95659 | GEO

Gene expression from embryoid bodies derived from HBG3 HB9 ES cells exposed to serum from a murine Huntington's disease model

Project description:We have established proof of principle for the Indicator Cell Assay Platformé (iCAPé), a broadly applicable tool for blood-based diagnostics that uses specifically-selected, standardized cells as biosensors, relying on their innate ability to integrate and respond to diverse signals present in patients' blood. To develop an assay, indicator cells are exposed in vitro to serum from case or control subjects and their global differential response patterns are used to train reliable, cost-effective disease classifiers based on a small number of features. In a feasibility study, the iCAP detected pre-symptomatic disease in a murine model of amyotrophic lateral sclerosis (ALS) with 94% accuracy (p-Value=3.81E-6) and correctly identified samples from a murine Huntington's disease model as non-carriers of ALS. In a preliminary human disease assay, the iCAP detected early stage Alzheimer's disease with 72% cross-validated accuracy (p-Value=3.10E-3). For both assays, iCAP features were enriched for disease-related genes, supporting the assay's relevance for disease research.

2017-03-17 | GSE95842 | GEO

Saccharomyces cerevisiae

Project description:Double-tiled DNA microarrays -- proof of principle

| PRJNA97017 | ENA

Homo sapiens

Project description:Proof of principle of novel technique of methylation analysis

| PRJNA124665 | ENA

Homo sapiens

Project description:HIT T cell versus B cell line proof-of-principle

| PRJNA107545 | ENA

Denitrifying bacterial assemblages respond to environmental conditions of a shallow estuary

Project description:Molecular analysis of dissimilatory nitrite reductase genes (nirS) was conducted using a customized microarray containing 165 nirS probes (archetypes) to identify members of sedimentary denitrifying communities. The goal of this study was to examine denitrifying community responses to changing environmental variables over spatial and temporal scales in the New River Estuary (NRE), NC, USA. Multivariate statistical analyses revealed three denitrifier assemblages and uncovered “generalist” and “specialist” archetypes based on the distribution of archetypes within these assemblages. Generalists, archetypes detected in all samples during at least one season, were commonly world-wide found in estuarine and marine ecosystems, comprised 11-29% of the abundant NRE archetypes. Archetypes found in a particular site, “specialists”, were found to co-vary based on site specific conditions. Archetypes specific to the lower estuary in winter were designated Cluster I and significantly correlated by sediment Chl a and porewater Fe2+. A combination of specialist and more widely distributed archetypes formed Clusters II and III, which separated based on salinity and porewater H2S, respectively. The co-occurrence of archetypes correlated with different environmental conditions highlights the importance of habitat type and niche differentiation among denitrifying communities and supports the essential role of individual community members in overall ecosystem function.

2017-05-02 | GSE98190 | GEO

Pre-clinical proof of principle for orally delivered Th17 antagonist miniproteins

Project description:Pre-clinical proof of principle for orally delivered Th17 antagonist miniproteins

| PRJNA1096346 | ENA